Contact your healthcare provider if youve skipped two or more consecutive weeks of Wegovy
*In a 68- and 72-week clinical trial studying Wegovy (2.4 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)
Additionally, studies in rats have shown an elevated risk of medullary thyroid carcinoma in rodents exposed to the peptide
What is missing from the gym version of the conversation is the part that protects the patient: licensing, clinical evaluation, regulated sourcing, and follow up
By purchasing this product, you acknowledge that: You are a qualified researcher or authorized laboratory representative